These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

152 related articles for article (PubMed ID: 25112387)

  • 1. Look carefully to the heels! A potentially treatable cause of spastic paraplegia.
    Saute JA; Giugliani R; Merkens LS; Chiang JP; DeBarber AE; de Souza CF
    J Inherit Metab Dis; 2015 Mar; 38(2):363-4. PubMed ID: 25112387
    [No Abstract]   [Full Text] [Related]  

  • 2. Cerebrotendinous xanthomatosis: recurrence of the CYP27A1 mutation p.Arg479Cys in Sardinia.
    Mandrile G; Gallus GN; Mura G; Di Sapio A; Sotgiu MA; Montella A; Giachino DF; Dotti MT; Ulgheri L; Federico A
    Neurol Sci; 2014 Aug; 35(8):1303-5. PubMed ID: 24584636
    [No Abstract]   [Full Text] [Related]  

  • 3. Oromandibular dystonia as a complication of cerebrotendinous xanthomatosis.
    Alcalay R; Wu S; Patel S; Frucht S
    Mov Disord; 2009 Jul; 24(9):1397-9. PubMed ID: 19373932
    [No Abstract]   [Full Text] [Related]  

  • 4. Cerebrotendinous Xanthomatosis: A Treatable Genetic Disease Not to Be Missed.
    Varman KM; Dunbar K; Usifo K; Stevens CA
    J Clin Rheumatol; 2016 Mar; 22(2):92-3. PubMed ID: 26906304
    [No Abstract]   [Full Text] [Related]  

  • 5. A case of cerebrotendinous xanthomatosis presenting with epilepsy as an initial symptom with a novel V413D mutation in the CYP27A1 gene.
    Koyama S; Kawanami T; Tanji H; Arawaka S; Wada M; Saito N; Kato T
    Clin Neurol Neurosurg; 2012 Sep; 114(7):1021-3. PubMed ID: 22336472
    [No Abstract]   [Full Text] [Related]  

  • 6. Clinical and radiological findings of a cerebrotendinous xanthomatosis patient with a novel p.A335V mutation in the CYP27A1 gene.
    Yoshinaga T; Sekijima Y; Koyama S; Maruyama K; Yoshida T; Kato T; Ikeda S
    Intern Med; 2014; 53(23):2725-9. PubMed ID: 25447658
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A double CYP27A1 gene mutation in spinal cerebrotendinous xanthomatosis in a patient presenting with spastic gait: a case report.
    Min JH; Kim YS; Son MJ; Joo IS
    J Med Case Rep; 2024 Jul; 18(1):334. PubMed ID: 38987800
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cerebrotendinous Xanthomatosis ataxia responsive to CDCA and Riluzole.
    Weissfeld T; Ratliff J
    J Clin Neurosci; 2018 Jul; 53():263-264. PubMed ID: 29731275
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The wide spectrum of cerebrotendinous xanthomatosis: Case report of a rare but treatable disease.
    Rosafio F; Cavallieri F; Guaraldi P; Taroni F; Nichelli PF; Mandrioli J
    Clin Neurol Neurosurg; 2016 Apr; 143():1-3. PubMed ID: 26874936
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Cerebrotendinous xanthomatosis, a treatable metabolic disorder].
    Heller R; Grau AJ; Schäbitz WR; Schwaninger M
    Nervenarzt; 2002 Dec; 73(12):1160-6. PubMed ID: 12486565
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A Late-onset and Relatively Rapidly Progressive Case of Pure Spinal Form Cerebrotendinous Xanthomatosis with a Novel Mutation in the CYP27A1 Gene.
    Takasone K; Morizumi T; Nakamura K; Mochizuki Y; Yoshinaga T; Koyama S; Sekijima Y
    Intern Med; 2020 Oct; 59(20):2587-2591. PubMed ID: 32581172
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cerebrotendinous xanthomatosis (CTX): a treatable lipid storage disease.
    Keren Z; Falik-Zaccai TC
    Pediatr Endocrinol Rev; 2009 Sep; 7(1):6-11. PubMed ID: 19696711
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Not Available].
    Eggertsen G; Puschmann A; Hall S; Wärme AK; Kvorning O; Olin M; Eriksson M; Björkhem I
    Lakartidningen; 2018 Sep; 115():. PubMed ID: 30252124
    [No Abstract]   [Full Text] [Related]  

  • 14. [Cerebrotendinous xanthomatosis is a rare disorder, which requires a specific treatment].
    Blaabjerg M; Marjanovic D
    Ugeskr Laeger; 2013 Jan; 175(5):285-6. PubMed ID: 23369332
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Diagnostic challenge: A case of late-onset spinal form cerebrotendinous xanthomatosis.
    Mutlu D; Tuncer A; Gocmen R; Yalcin-Cakmakli G; Saygı S; Elibol B
    Neurology; 2019 Feb; 92(9):438-439. PubMed ID: 30804055
    [No Abstract]   [Full Text] [Related]  

  • 16. Cerebrotendinous xanthomatosis in three siblings from a Chinese family.
    Ko KF; Lee KW
    Singapore Med J; 2001 Jan; 42(1):30-2. PubMed ID: 11361235
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Double trouble: a case of an ataxic young man with coeliac disease and cerebrotendinous xanthomatosis.
    Burgess J; Behzad-Noori D; Longman C; Brennan K
    BMJ Case Rep; 2020 Dec; 13(12):. PubMed ID: 33370991
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Cerebrotendinous xanthomatosis--a treatable metabolic disorder].
    Sperhake JP; Matschke J
    Nervenarzt; 2004 Jun; 75(6):608. PubMed ID: 15257383
    [No Abstract]   [Full Text] [Related]  

  • 19. Brain diffusion tensor imaging changes in cerebrotendinous xanthomatosis reversed with treatment.
    Catarino CB; Vollmar C; Küpper C; Seelos K; Gallenmüller C; Bartkiewicz J; Biskup S; Hörtnagel K; Klopstock T
    J Neurol; 2018 Feb; 265(2):388-393. PubMed ID: 29260356
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Presenile cataract: consider cholestanol.
    Tészás A; Pfund Z; Morava E; Kosztolányi G; Sistermans E; Wevers RA; Kellermayer R
    Arch Ophthalmol; 2006 Oct; 124(10):1490-2. PubMed ID: 17030721
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 8.